Medicinal Products

Rixathon

Name Rixathon
Active Substance rituximab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC02
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Edukacijska brošura za liječnike neonkološke indikacije, verzija 1, 10
Kartica upozorenja za zdravstvene radnike Rixathon, verzija 1, 10
Educational materials
for patients / caregivers
Edukacijska brošura za bolesnike neonkološke indikacije, verzija 1, 10

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/rixathon

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back